GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Rating:
Mkt Underperform
MDVN
down 89.05 %

MEDIVATION INC (MDVN) rated Mkt Underperform with price target $29 by Rodman & Renshaw

Posted on: Thursday,  Nov 10, 2011  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Underperform MEDIVATION INC (NASDAQ: MDVN) on 11/10/2011. Previously Rodman & Renshaw rated Mkt Underperform MEDIVATION INC (NASDAQ: MDVN)
on 04/11/2011., when the stock price was $10.08. Since then, MEDIVATION INC has gained 813.39% as of 01/27/2016's recent price of $92.07.
If you would have followed the previous Rodman & Renshaw's recommendation on MDVN, you would have lost 89.05% of your investment in 1752 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/10/2011 8:25 AM Sell
None
21.11 14.50
as of 12/30/2011
1 Week down  -1.02 %
1 Month down  -0.34 %
3 Months down  -171.55 %
1 YTD up  23.66 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/11/2011 12:25 PM Sell
None
10.08
7/8/2008 8:25 AM Buy
None
6.05 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy